IP² Launchpad Manager
2020年3月1日1 分鐘
Israeli company BATM of Hod Hasharon announced that its biomedical division has developed a diagnostics kit to detect coronavirus from saliva samples in less than half an hour.
CEO Dr. Zvi Marom tells ISRAEL21c that the test is compatible with the current hospital-based method for diagnosing COVID-19, reverse-transcription polymerase chain reaction (RT-PCR) – a type of gene sequencing that takes about eight hours.
“This kit has undergone testing by several central laboratories and hospitals that have now verified its ability to diagnose COVID-19,” says Marom, referring to the disease caused by coronavirus infection.
“BATM is working with academic and research institutions, mainly in Europe, to progress the kit to make it at a price point suitable for large-scale production,” says Marom. “The kit, which supports all the Centers for Disease Control and Prevention (CDC) recommendations, has already received interest from customers in several countries.”